Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

The long-term control strategy of SARS-CoV-2 and other major respiratory viruses needs to include antivirals to treat acute infections, in addition to the judicious use of effective vaccines. Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use o...

Full description

Bibliographic Details
Main Authors: Sarah Al-Beltagi, Cristian Alexandru Preda, Leah V. Goulding, Joe James, Juan Pu, Paul Skinner, Zhimin Jiang, Belinda Lei Wang, Jiayun Yang, Ashley C. Banyard, Kenneth H. Mellits, Pavel Gershkovich, Christopher J. Hayes, Jonathan Nguyen-Van-Tam, Ian H. Brown, Jinhua Liu, Kin-Chow Chang
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Viruses
Subjects:
thapsigargin
inhibitor
antiviral
SARS-CoV-2
coronavirus OC43
respiratory syncytial virus
Online Access:https://www.mdpi.com/1999-4915/13/2/234

Similar Items

Similar Items